Search
for
Sort by
Research 661–690 of 1000+
- Novel complex of cosmetic ingredients with promising action in preventing hair loss and follicular aging through mechanism involving enrichment of <i>WNT</i>/signaling, mitochondrial activity, and stem cells maintenance
- Trichostasis spinulosa of the scalp mimicking Alopecia Areata black dots
- Peptichemio: A New Oncolytic Drug in Combination with Vincristine and Prednisolone in the Treatment of Non-Hodgkin Lymphomas
- Chikungunya virus infection in the skin: histopathology and cutaneous immunological response
- COVID-19 Severity and Androgen Receptor Polymorphism
- The diagnosis of androgenetic alopecia in children: Considerations of pathophysiological plausibility
- Adult-onset Satoyoshi syndrome in a young male
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia
- Alterações dermatológicas em pacientes oncológicos – adultos e crianças
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Use of vibrating anesthetic device reduces the pain of mesotherapy injections: A randomized split‐scalp study
- In vitro identification of a stem cell population from canine hair follicle bulge region
- Porocarcinoma: an epidemiological, clinical, and dermoscopic 20‐year study
- Straight to the Point: What Do We Know So Far on Hair Straightening?
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Efficacy of Topical Finasteride 0.5% vs 17α-Estradiol 0.05% in the Treatment of Postmenopausal Female Pattern Hair Loss: A Retrospective, Single-Blind Study of 119 Patients
- In Vivo Reflectance Confocal Microscopy in General Dermatology: How to Choose the Right Indication
- Tratamento de queimaduras de carboxiterapia em modelo experimental
- Interleukin‐1 family cytokines and soluble receptors in hidradenitis suppurativa
- Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis
- Effects of chemical straighteners on the hair shaft and scalp
- Permanent alopecia as a manifestation of chronic graft-versus-host disease of the scalp: clinical, dermoscopic and histopathological observations
- Chemotherapy-induced alopecia: A novel observation